世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038596

自己注射器の世界市場(2024-2028)

TechNavio

Global autoinjectors market 2024-2028

発刊日 2024/05/21

言語英語

体裁PDF/176ページ

ライセンス/価格176ページ

0000038596

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

自己注射器市場は2023年から2028年に3,036億5,540万米ドルの成長が見込まれ、予測期間中のCAGRは36.72%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、アレルギーの蔓延と即時治療の必要性の増加、注射療法の人気の高まり、新製品の商業承認の増加によって推進されています。

調査範囲

  • 市場セグメント
    ➣ 用途別
      ◇ アナフィラキシー
      ◇ 多発性硬化症
      ◇ 関節リウマチ
      ◇ 糖尿病
    ➣ エンドユーザー別
      ◇ 病院・クリニック
      ◇ 自己管理
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域

本調査では、企業間の戦略的提携が、今後数年間の自己注射器市場の成長を牽引する主な理由の1つであると特定しています。また、新製品の発売の増加と革新的なアナフィラキシー自己注射器の認知度の高まりにより、市場でかなりの需要が生まれるでしょう。

自己注射器市場に関するレポートは、次の分野をカバーしています。

  • 自己注射器市場の規模
  • 自己注射器市場の予測
  • 自己注射器市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ AbbVie Inc.
    ➣ Amgen Inc.
    ➣ Bayer AG
    ➣ Becton Dickinson and Co.
    ➣ Eli Lilly and Co.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ GlaxoSmithKline Plc
    ➣ Halozyme Therapeutics Inc.
    ➣ Johnson and Johnson Services Inc.
    ➣ Johnson Medtech LLC
    ➣ medmix Ltd.
    ➣ Merck KGaA
    ➣ Owen Mumford Ltd.
    ➣ Pfizer Inc.
    ➣ RAVIMED Sp. zoo
    ➣ Recipharm AB
    ➣ SHL Medical AG
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Viatris Inc.
    ➣ Ypsomed Holding AG

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Autoinjectors Market 2018 - 2022
Historic Market Size - Data Table on Global Autoinjectors Market 2018 - 2022 ($ million)
4.2 Application segment analysis 2018 - 2022
Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application
6.1 Market segments
Chart on Application - Market share 2023-2028 (%)
Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
6.3 Anaphylaxis - Market size and forecast 2023-2028
Chart on Anaphylaxis - Market size and forecast 2023-2028 ($ million)
Data Table on Anaphylaxis - Market size and forecast 2023-2028 ($ million)
Chart on Anaphylaxis - Year-over-year growth 2023-2028 (%)
Data Table on Anaphylaxis - Year-over-year growth 2023-2028 (%)
6.4 Multiple sclerosis - Market size and forecast 2023-2028
Chart on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
Chart on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
6.5 Rheumatoid arthritis - Market size and forecast 2023-2028
Chart on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
Data Table on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
Chart on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
Data Table on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
6.6 Diabetes - Market size and forecast 2023-2028
Chart on Diabetes - Market size and forecast 2023-2028 ($ million)
Data Table on Diabetes - Market size and forecast 2023-2028 ($ million)
Chart on Diabetes - Year-over-year growth 2023-2028 (%)
Data Table on Diabetes - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by End-user
7.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
7.3 Hospitals and clinics - Market size and forecast 2023-2028
Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
7.4 Self-administration - Market size and forecast 2023-2028
Chart on Self-administration - Market size and forecast 2023-2028 ($ million)
Data Table on Self-administration - Market size and forecast 2023-2028 ($ million)
Chart on Self-administration - Year-over-year growth 2023-2028 (%)
Data Table on Self-administration - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
12.5 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.6 Becton Dickinson and Co.
Becton Dickinson and Co. - Overview
Becton Dickinson and Co. - Business segments
Becton Dickinson and Co. - Key news
Becton Dickinson and Co. - Key offerings
Becton Dickinson and Co. - Segment focus
12.7 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.9 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.10 Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc. - Overview
Halozyme Therapeutics Inc. - Product / Service
Halozyme Therapeutics Inc. - Key offerings
12.11 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
12.12 Owen Mumford Ltd.
Owen Mumford Ltd. - Overview
Owen Mumford Ltd. - Product / Service
Owen Mumford Ltd. - Key offerings
12.13 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.14 Recipharm AB
Recipharm AB - Overview
Recipharm AB - Business segments
Recipharm AB - Key offerings
Recipharm AB - Segment focus
12.15 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
12.16 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
12.17 Ypsomed Holding AG
Ypsomed Holding AG - Overview
Ypsomed Holding AG - Business segments
Ypsomed Holding AG - Key offerings
Ypsomed Holding AG - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Autoinjectors Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Application - Market share 2023-2028 (%)
Exhibits33: Data Table on Application - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Application
Exhibits35: Data Table on Comparison by Application
Exhibits36: Chart on Anaphylaxis - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Anaphylaxis - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Anaphylaxis - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Anaphylaxis - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Multiple sclerosis - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Multiple sclerosis - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Rheumatoid arthritis - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Rheumatoid arthritis - Year-over-year growth 2023-2028 (%)
Exhibits48: Chart on Diabetes - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Diabetes - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Diabetes - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Diabetes - Year-over-year growth 2023-2028 (%)
Exhibits52: Market opportunity by Application ($ million)
Exhibits53: Data Table on Market opportunity by Application ($ million)
Exhibits54: Chart on End-user - Market share 2023-2028 (%)
Exhibits55: Data Table on End-user - Market share 2023-2028 (%)
Exhibits56: Chart on Comparison by End-user
Exhibits57: Data Table on Comparison by End-user
Exhibits58: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on Self-administration - Market size and forecast 2023-2028 ($ million)
Exhibits63: Data Table on Self-administration - Market size and forecast 2023-2028 ($ million)
Exhibits64: Chart on Self-administration - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Self-administration - Year-over-year growth 2023-2028 (%)
Exhibits66: Market opportunity by End-user ($ million)
Exhibits67: Data Table on Market opportunity by End-user ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits111: Impact of drivers and challenges in 2023 and 2028
Exhibits112: Overview on criticality of inputs and factors of differentiation
Exhibits113: Overview on factors of disruption
Exhibits114: Impact of key risks on business
Exhibits115: Companies covered
Exhibits116: Matrix on companies position and classification
Exhibits117: AbbVie Inc. - Overview
Exhibits118: AbbVie Inc. - Product / Service
Exhibits119: AbbVie Inc. - Key news
Exhibits120: AbbVie Inc. - Key offerings
Exhibits121: Amgen Inc. - Overview
Exhibits122: Amgen Inc. - Product / Service
Exhibits123: Amgen Inc. - Key news
Exhibits124: Amgen Inc. - Key offerings
Exhibits125: Bayer AG - Overview
Exhibits126: Bayer AG - Business segments
Exhibits127: Bayer AG - Key news
Exhibits128: Bayer AG - Key offerings
Exhibits129: Bayer AG - Segment focus
Exhibits130: Becton Dickinson and Co. - Overview
Exhibits131: Becton Dickinson and Co. - Business segments
Exhibits132: Becton Dickinson and Co. - Key news
Exhibits133: Becton Dickinson and Co. - Key offerings
Exhibits134: Becton Dickinson and Co. - Segment focus
Exhibits135: Eli Lilly and Co. - Overview
Exhibits136: Eli Lilly and Co. - Product / Service
Exhibits137: Eli Lilly and Co. - Key news
Exhibits138: Eli Lilly and Co. - Key offerings
Exhibits139: F. Hoffmann La Roche Ltd. - Overview
Exhibits140: F. Hoffmann La Roche Ltd. - Business segments
Exhibits141: F. Hoffmann La Roche Ltd. - Key news
Exhibits142: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits143: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits144: GlaxoSmithKline Plc - Overview
Exhibits145: GlaxoSmithKline Plc - Business segments
Exhibits146: GlaxoSmithKline Plc - Key news
Exhibits147: GlaxoSmithKline Plc - Key offerings
Exhibits148: GlaxoSmithKline Plc - Segment focus
Exhibits149: Halozyme Therapeutics Inc. - Overview
Exhibits150: Halozyme Therapeutics Inc. - Product / Service
Exhibits151: Halozyme Therapeutics Inc. - Key offerings
Exhibits152: Merck KGaA - Overview
Exhibits153: Merck KGaA - Business segments
Exhibits154: Merck KGaA - Key news
Exhibits155: Merck KGaA - Key offerings
Exhibits156: Merck KGaA - Segment focus
Exhibits157: Owen Mumford Ltd. - Overview
Exhibits158: Owen Mumford Ltd. - Product / Service
Exhibits159: Owen Mumford Ltd. - Key offerings
Exhibits160: Pfizer Inc. - Overview
Exhibits161: Pfizer Inc. - Product / Service
Exhibits162: Pfizer Inc. - Key news
Exhibits163: Pfizer Inc. - Key offerings
Exhibits164: Recipharm AB - Overview
Exhibits165: Recipharm AB - Business segments
Exhibits166: Recipharm AB - Key offerings
Exhibits167: Recipharm AB - Segment focus
Exhibits168: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits169: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits170: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits171: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits172: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits173: Viatris Inc. - Overview
Exhibits174: Viatris Inc. - Business segments
Exhibits175: Viatris Inc. - Key news
Exhibits176: Viatris Inc. - Key offerings
Exhibits177: Viatris Inc. - Segment focus
Exhibits178: Ypsomed Holding AG - Overview
Exhibits179: Ypsomed Holding AG - Business segments
Exhibits180: Ypsomed Holding AG - Key offerings
Exhibits181: Ypsomed Holding AG - Segment focus
Exhibits182: Inclusions checklist
Exhibits183: Exclusions checklist
Exhibits184: Currency conversion rates for US$
Exhibits185: Research methodology
Exhibits186: Information sources
Exhibits187: Data validation
Exhibits188: Validation techniques employed for market sizing
Exhibits189: Data synthesis
Exhibits190: 360 degree market analysis
Exhibits191: List of abbreviations

この商品のレポートナンバー

0000038596

TOP